drugset / Trial / NCT02934555
Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest
Phase 2
Completed
48 enrolled
Beth Israel Deaconess Medical Center
Kaneka Medical America LLC · collab
RandomizedParallel-groupQuadruple-blindOther
Summary
To study the effects of ubiquinol as a "metabolic resuscitator" in post-cardiac arrest.
Timeline
- Start
- 2016-03
- Primary completion
- 2019-05-25
- Completion
- 2019-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ubiquinol | Unknown | 300 mg | — |